Medicines
NAS:MDCO
Pharmaceuticals: Other
—
MID cap
(—)
—
since start of 2022
—
About
Pharmaceuticals: OtherFounded 1996
The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on leading acute and intensive care hospitals worldwide. The company markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
Headquarters
Executives
Name | Title | Gender |
Loretta M. Itri, MD | EVP-Global Health Science & Regulatory Affairs | Female |
Tony Kingsley, MBA | President & Chief Operating Officer | Male |
Bill O'Connor, CPA | SVP, Chief Financial & Accounting Officer | Male |
Fred Eshelman, PhD | Non-Executive Chairman | Male |
Clive A. Meanwell, MD, PhD | Chief Executive Officer & Director | Male |
John W. Villiger, PhD | Executive Vice President | Male |
T. Scott Johnson, MD | Founder | Male |
Helmut Giersiefen, PhD | Founder | Male |
Krishna Gorti, MD | Vice President-Investor Relations | Male |
David Kallend, Phd | Vice President & Global Medical Director | Male |
Stephen M. Rodin | Secretary, Senior Vice President & General Counsel | Male |
Mindful Investing Summary
Medicines - Competitors and Related Companies
How Medicines stacks up to its peers in thePharmaceuticals: Other industry or with competing business segments.
Medicines
NAS:MDCO
Pharmaceuticals: Other
—
MID cap
(—)
—
since start of 2022
—
Eagle Pharmaceuticals
NAS:EGRX
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2022
—
Innoviva
NAS:INVA
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2022
—
Momenta Pharmaceuticals
NAS:MNTA
Biotechnology
—
SMALL cap
(—)
—
since start of 2022
—
Bristol-Myers Squibb
NYS:BMY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—
Eli Lilly
NYS:LLY
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2022
—